Golden Biotechnology Corporation announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 36.195 million compared to TWD 43.595 million a year ago. Operating loss was TWD 203.503 million compared to TWD 132.190 million a year ago. Net loss was TWD 219.689 million compared to TWD 142.615 million a year ago. Basic loss per share was TWD 1.66 compared to TWD 1.18 a year ago.